patent/CN-107530403-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107530403-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bab51dbb81468c1c6978289aacc6d60a
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
filingDate	2015-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e25bf502974c98d230c36a0ec0378f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_326fe70d24bbfd05ccb5832da9ad1693 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d89750417cfc574c6fec23727f3b859c
publicationDate	2018-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-107530403-A
titleOfInvention	Dosage regimen for peginterferon
abstract	A pegylated type I interferon for the treatment of infectious disease, cancer or myeloproliferative disease in an individual in need thereof, wherein the pegylated type I interferon is administered at regular intervals in a dose of 50 to 540 μg The subject is treated for a period of time, the interval being 3 to 8 weeks.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110295218-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110295218-B
priorityDate	2014-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102724980-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102724980-B
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466876885

Total number of triples: 33.